Decibel Cannabis Company Inc. reports news on its Canadian branded cannabis business, including adult-use products, premium cannabis and extract manufactured products, and global medical exports. The company’s portfolio includes General Admission, Qwest and Standard Issue, supported by Canadian cultivation, processing and manufacturing facilities, including an EU GMP licensed cultivation and processing facility in Chatham, Ontario.
Recurring updates cover quarterly and annual financial results, domestic brand performance, international sales, AgMedica integration, credit facilities, stock option grants, shareholder meeting results and other governance matters.
Decibel Cannabis Company (DBCCF) outlined Ewing Morris Avenue LP's unsolicited offer to buy existing shareholders' shares for $1.91 cash per share. The offer covers up to 2,617,801 shares, approximately 6.8% of outstanding shares, for approximately $5.0 million. The price is approximately 16.4% above the 20-trading-day volume-weighted average before the offer announcement and approximately 19.4% above the October 16, 2026 closing price.
Decibel is not a party, will receive no proceeds and will issue no securities. The offer requires at least 1,745,200 shares to be deposited and carries other conditions; excess deposits face proportional acceptance. Expiry is 5:00 p.m. Eastern Standard Time on November 6, 2026, unless extended, varied or withdrawn. Management and directors do not intend to tender. Neither Decibel nor its board recommends whether shareholders should participate.
Decibel Cannabis Company (DBCCF) announced that Adam Coates has resigned from his position as Chief Revenue Officer of the company.
Decibel will integrate the role's responsibilities, primarily focused on domestic commercial oversight, into its existing leadership team. The company also plans to align its commercial team with its domestic and international business units.
Decibel Cannabis Company (DBCCF) has signed a brand licensing agreement with Hilltop Leaf to launch its flower portfolio in the United Kingdom. The agreement grants Hilltop a limited UK license for Decibel's General Admission and Standard Issue brands. The initial rollout is planned for Q4 2026, with fifteen product lines under those two brands alongside six Hilltop Leaf branded product lines.
The arrangement includes exports of finished, packaged medical products to the UK through an end-to-end supply chain qualified under EU Good Manufacturing Practice standards. Both companies comply with the regulations required to supply medical-grade, quality-assured cannabis-based medicinal products into the UK. Decibel views the partnership as a further step in developing its international platform and diversifying revenue.
Decibel Cannabis Company (OTCQB: DBCCF, TSXV: DB) confirmed that its previously approved 15:1 consolidation of issued and outstanding common shares is now effective as of market open on September 1, 2026. Trading on a post-consolidation basis on the TSX Venture Exchange is expected to commence at market open the same day, under the same company name and trading symbols, but with a new CUSIP number.
No fractional shares will be issued, with any fractions rounded down to the nearest whole share. Registered shareholders will receive a letter of transmittal from Odyssey Trust Company with instructions to exchange pre-consolidation share certificates or DRS statements for post-consolidation holdings, while non-registered shareholders must follow procedures set by their intermediaries.
Decibel (OTCQB: DBCCF) reported record Q2 2026 results, with net revenue of $35.6 million, up 19% year over year. International sales rose 72% to $10.6 million, gross margin before fair value adjustments reached 51%, adjusted EBITDA was $7.8 million (+24% YoY) and free cash flow was $4.9 million (+122% YoY).
According to the company, full-year 2026 guidance was raised to $132–$137 million in net revenue and $28–$32 million in adjusted EBITDA. Decibel announced a 15:1 share consolidation, reducing outstanding shares from about 577.0 million to approximately 38.5 million, subject to TSXV acceptance, with post-consolidation trading expected around September 1, 2026. The company is also considering a Normal Course Issuer Bid and appointed Shawn Dym as Executive Chairman, with Nadia Vattovaz as Lead Independent Director.
Decibel Cannabis Company (OTCQB: DBCCF) will release its second quarter 2026 financial results pre-market on Thursday, August 20, 2026. Management will host a live conference call at 10:00 a.m. MDT the same day to review and discuss the results.
According to Decibel, Canadian participants can join by dialing 1-800-715-9871 and U.S. participants by dialing 1-888-880-3330, using conference ID 6188739, or by accessing the online registration link. Decibel highlights its branded cannabis products, international medical exports, and facilities in Alberta, Saskatchewan and Ontario.
Decibel (OTCQB:DBCCF) reported Q1 2026 net revenue of $29.8M, up 41% year over year, with international sales rising 330% to $9.6M and domestic sales up 7% to $20.3M. Adjusted EBITDA reached $6.9M and gross margin before fair value adjustments was 51%.
Q2 2026 net revenue guidance is $33–35M, and full‑year 2026 guidance is $130–135M net revenue and $27–31M Adjusted EBITDA. Decibel closed a new $61M ATB credit facility and agreed to sell its Creston cultivation property for $2.5M, expected to save about $4M annually.
Decibel Cannabis (OTCQB:DBCCF) will release its first quarter 2026 financial results pre-market on Thursday, May 21, 2026. Management will host a live conference call at 10:00 a.m. MST the same day, with phone and online registration options available for participants.
Decibel (OTCQB: DBCCF) reported 2025 net revenue of $112.7M, up 22%, with Adjusted EBITDA $23.2M (+29%) and Free Cash Flow $5.5M (+292%). International sales rose to $24.2M (+484%). Decibel issued 2026 guidance: revenue $130–135M and Adjusted EBITDA $27–31M, and closed a new $61M credit facility in February 2026.
Decibel Cannabis Company (OTCQB: DBCCF) will report Q4 2025 financial results pre-market on April 16, 2026. A live conference call is scheduled at 10:00 a.m. MDT the same day with Canadian and U.S. dial-ins and conference ID 6569457.
Decibel describes itself as a Canadian branded cannabis manufacturer with consumer brands General Admission, Qwest and Standard Issue and facilities in Calgary, Battleford and Chatham (EU GMP licensed).